Autocrine role of gonadotropin-releasing hormone and its receptor in ovarian cancer cell growth

Author： Kang Sung Cheng Kwai Nathwani Parimal Choi Kyung-Chul Leung Peter

ISSN： 0969-711X

Source： Endocrine Journal, Vol.13, Iss.3, 2000-12, pp. : 297-304

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

We have recently proposed an autocrine role of gonadotropin-releasing hormone (GnRH) and its receptor (GnRH-R) in human ovarian surface epithelium. In the present study, we examine the presence and role of a GnRH/GnRH-R loop in epithelial ovarian cancer cells, OVCAR-3. A dose-dependent biphasic response in GnRH and GnRH-R mRNA levels were observed after treating with GnRH agonist [GnRHa, (D-Ala⁶)-GnRH], for 24 h. High concentrations of GnRHa (10⁻⁹ M and 10⁻⁷) decreased the GnRH and GnRH-R mRNA levels, whereas a low concentration (10⁻¹¹ M) resulted in an upregulation of GnRH and GnRH-R genes expression. Cotretment with the competitive antagonist, antide, prevented the biphasic effect induced by GnRHa, confirming the specificity of the response. In addition, GnRHa treatment resulted in a time- and dose-dependent inhibition on OVCAR-3 cells growth. A significant inhibition of proliferation was detected as early as the d2 of treatment. Treatment with 10⁻⁷ M GnRHa induced DNA fragmentation in OVCAR-3 cells, suggesting that the GnRHa-induced antiproliferation in OVCAR-3 cells was mediated by apoptosis. Again, this effect was prevented by cotreatment of antide. Taken together, our findings strongly support the notion that GnRH acts as an autocrine/paracrine regulator of ovarian cancer cell proliferation.